tales from the trenches
Corey McCann answers: Can an app be as good as a drug?
Corey McCann, founder and CEO of PEAR Therapeutics, is among the trailblazing entrepreneurs developing “digital therapeutics”: a new class of software solutions that undergo clinical studies to prove efficacy. Last fall, PEAR’s reSET® technology — designed to treat patients with substance use disorder — became the first FDA-cleared prescription digital therapeutic for disease treatment.
Corey …
Read more